Shan Zha (Hawthorn Fruit)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Shan Zha?

  Roughly 9–15 g in decoction, with a commonly cited upper ceiling around 30 g. Chen & Chen give about 10–15 g (maximum 30 g); Bensky gives about 9–12 g. Raw versus stir-fried/charred processing shifts the herb’s emphasis (see notes) rather than its basic dose range.

  Source: Sacred Lotus sources & references; Bensky/Chen & Chen standard ranges. Reference only, not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Shan Zha?

  Do not use during pregnancy, given its blood-invigorating action, and use with caution in cases of Spleen and Stomach deficiency or gastritis/peptic ulcer, since the herb’s natural acidity/sourness can aggravate acid-related irritation. It is not intended for long-term, unsupervised use, as this can impair the normal flow of Spleen and Stomach qi.

  • Pregnancy — contraindicated.
  • Spleen and Stomach deficiency — use with caution.
  • Gastritis or peptic ulcer — use with caution due to the herb’s acidity.
  • Long-term use — avoid prolonged use, as it can harm the flow of Spleen and Stomach qi.

  Source: cross-referenced against multiple online sources; Bensky/Chen & Chen cautions.

Chinese Herb Toxicity & Overdose

• Low. Hawthorn (Crataegus spp.) is a food-grade fruit with a long dietary history (jams, candies, teas) and no significant toxicity reported at typical food or medicinal doses in the literature reviewed.

  Source: cross-referenced against multiple online sources; materia medica consensus. Reference note, not a safety guarantee.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented specifically for Shan Zha at traditional TCM decoction doses. Given its documented (though mixed) cardiovascular and lipid-modulating pharmacology (see research), Western herb–drug interaction literature on hawthorn (Crataegus) preparations flags potential additive effects with antihypertensive medications, digoxin/cardiac glycosides, and lipid-lowering therapy — a precautionary flag for practitioner awareness with concurrent use, not a demonstrated clinical interaction specific to TCM-dose Shan Zha. (Flagged for practitioner confirmation.)

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there research on Shan Zha (Crataegus/hawthorn) and cardiovascular health?

  Yes — hawthorn has one of the more substantial Western clinical research bases of any single TCM herb, concentrated on chronic heart failure and lipid/cholesterol effects, though results are mixed rather than uniformly positive.

  • Chronic heart failure (systematic review) — a Cochrane systematic review of hawthorn extract as adjunctive treatment for chronic heart failure found evidence of benefit for some symptomatic/physiologic outcomes across included trials, while flagging inconsistency and calling for larger trials.
  • Chronic heart failure (meta-analysis and RCT) — an earlier meta-analysis of pooled randomized trials reported improved exercise tolerance and symptoms with adjunctive hawthorn extract, and a placebo-controlled randomized trial of the standardized extract WS 1442 in NYHA class III heart failure reported benefit on exercise tolerance and symptoms versus placebo.
  • Chronic heart failure (larger, later trial) — the NIH-funded HERB-CHF randomized trial, in a more advanced heart-failure population, found no significant improvement in exercise tolerance or quality of life versus placebo — a notable discrepancy against the earlier, more positive literature that tempers the overall picture.
  • Lipid/cholesterol (preclinical and clinical) — more recent trials report improved body-fat and lipid profiles in overweight adults given a Crataegus extract mixture, and improved lipid parameters with a Crataegus-based multiherb formula for dyslipidemia; a separate study of Crataegus laevigata reported hypolipidemic effects alongside reduced neutrophil elastase.

  Note: the null result of the large HERB-CHF trial sits in real tension with earlier, smaller positive meta-analyses and RCTs on hawthorn for heart failure; this is presented as an open, unresolved discrepancy in the research rather than resolved in either direction.

  Overall, this is a substantial but mixed evidence base, reported here as research context and not as a treatment claim.

  Sources: PMID 18254076 (Cochrane systematic review, chronic heart failure); PMID 12798455 (meta-analysis, chronic heart failure); PMID 12040357 (WS 1442 RCT, NYHA class III); PMID 19789403 (HERB-CHF randomized trial); PMID 38398818 (lipid/body-fat RCT, overweight adults); PMID 24834096 (Crataegus multiherb formula, dyslipidemia); PMID 21242072 (Crataegus laevigata, hypolipidemic effect); PMID 22228939 (review, hawthorn in cardiovascular disease).

Chinese Herb Notes

• What is the difference between raw Shan Zha and charred (chao/jiao) Shan Zha?

  Raw Shan Zha has a stronger blood-invigorating, stasis-dissipating action, while stir-fried or charred Shan Zha is milder, less sour/acidic on the stomach, and favored specifically for food stagnation and diarrhea — particularly in weaker or pediatric patients.

  • Raw (sheng) — stronger for invigorating blood and dissipating stasis (gynecological indications such as postpartum pain and amenorrhea); more sour/acidic, which can be harder on a sensitive stomach.
  • Stir-fried (chao) — gentler digestive/food-stagnation use with reduced sourness; a common choice for children.
  • Charred (jiao/tan) — used specifically to stop diarrhea, especially food-stagnation-type or chronic dysenteric diarrhea; charring further tempers the sour, blood-moving action while enhancing the astringent, stop-diarrhea effect.

  Key combinations (grounded in formula composition): Shan Zha is the chief herb in Bao He Wan (with Shen Qu, Lai Fu Zi, Chen Pi, Ban Xia, Fu Ling, and Lian Qiao) for food stagnation with heat, and appears in Jian Pi Wan for food stagnation with concurrent Spleen deficiency. (Traditional formula context, not treatment advice.)

  Source: cross-referenced against multiple online sources on paozhi (processing); Sacred Lotus sources & references (Bao He Wan/Jian Pi Wan composition); Bensky/Chen & Chen consensus.